Comparison of Two Financial Incentives to Encourage the Use of Adalimumab Biosimilars: Results of a French Experiment Close to Clinicians
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Comparison of Two Financial Incentives to Encourage the Use of Adalimumab Biosimilars: Results of a French Experiment Close to Clinicians ; day:2 ; month:7 ; year:2024 ; pages:1-13
PharmacoEconomics - open ; (2.7.2024), 1-13
- Creator
-
Tano, Marion
Paubel, Pascal
Ribault, Matthieu
Degrassat-Théas, Albane
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s41669-024-00505-7
- URN
-
urn:nbn:de:101:1-2409202141498.345465125373
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:38 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tano, Marion
- Paubel, Pascal
- Ribault, Matthieu
- Degrassat-Théas, Albane
- SpringerLink (Online service)
Other Objects (12)
Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis
Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity
Policies to Encourage the Use of Biosimilars in European Countries and Their Potential Impact on Pharmaceutical Expenditure
Biosimilars – Biosimilars: ja, aber
Biosimilars
Understanding the market dynamics of biosimilars
Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab
Biosimilars : Handbuch
Efficacy of adalimumab in sarcoidosis
Interchangeability of Biosimilars: Overcoming the Final Hurdles
Future of anti-VEGF: biosimilars and biobetters
Biosimilars : ein Handbuch
Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis
Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity
Policies to Encourage the Use of Biosimilars in European Countries and Their Potential Impact on Pharmaceutical Expenditure
Biosimilars – Biosimilars: ja, aber
Biosimilars
Understanding the market dynamics of biosimilars
Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab
Biosimilars : Handbuch
Efficacy of adalimumab in sarcoidosis
Interchangeability of Biosimilars: Overcoming the Final Hurdles
Future of anti-VEGF: biosimilars and biobetters
Biosimilars : ein Handbuch
Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis
Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity
Policies to Encourage the Use of Biosimilars in European Countries and Their Potential Impact on Pharmaceutical Expenditure
Biosimilars – Biosimilars: ja, aber
Biosimilars
Understanding the market dynamics of biosimilars
Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab
Biosimilars : Handbuch
Efficacy of adalimumab in sarcoidosis
Interchangeability of Biosimilars: Overcoming the Final Hurdles
Future of anti-VEGF: biosimilars and biobetters